Purchase Full Report of
Cancer Therapeutics Market by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others) and Top Selling Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
|
A00381
|
Pages: 261
|
Jul 2019
| 14514 Views
|
|
|
Author(s) :
Sohail Shaikh & Shreyashi Pajankar
|
Tables: 91
|
Charts: 71
|
Formats*: |
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste,download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,769$4,904 - Restricted to one authorized user
- One print only
- Available in
PDF - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,160 - Limited to five authorized users
- Print upto
five copies - Available in PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$6,746 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF Downloads
- 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
- Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD